The Bayh-Dole Act

• 35 USC 203, the Bayh-Dole Act "March In" provisions.
• 35 USC 200, the Bayh-Dole Act statement on Policy and Objective.

NIH Documents

• August, 1997. National Institutes of Health, Office of Director. Determination in the Case of Petition of CellPro, Inc.
• August 1997. Media Backgrounder
• NIH Index Page. Correspondence and Submissions Relating to CellPro March-In Petition. Consists of 39 official documents and a number of supporting documents.

• August 25, 1997. Johns Hopkins Press Release. Threat to Technology Transfer Averted.
• May 8, 1997. Baxter Press Release. Johns Hopkins Assures Department of Health and Human Services that Patient Access to Stem Cell Selection Technology Is Not at Risk.
• April 8, 1997. Baxter Press Release. Johns Hopkins, Becton Dickinson and Baxter Ask Court For Staged Injunction Aaginst Sale of CellPro Devices that Infringe Two Stem Cell Selection Patents.

• December, 2002. Avital Bar-Shalom and Robert Cook-Deegan in the Milbank Quarterly. Patents and Innovation in Cancer Therapies: Lessons from CellPro.
  • Abstract
  • December 11, 2002. Duke University press release. Patent policy flaws complicate commercialization of federally funded university discoveries.
  • January 5, 2003. Luke Timmerman for the Seattle Times. Biotech patent policy muscled away future of once-bright CellPro.
• Fall, 1999. Barbara M. McGarey and Annette C. Levey in the Berkley Technology Law Journal, Volume 14, Issue 3. Patents, Products, and Public Health: An Analysis of the CellPro March-In Petition.
• Spring, 1998. Kevin W. McCabe for the Public Contract Law Journal, Issue 27:3. Implications of the CellPro Determination on Inventions Made with Federal Assistance: Will the Government Ever Exercise Its March-In Right? (Abstract)
• 1997 Lorie K. Dakessian for Intellectual Property and Technology Forum, Boston College Law School. Another Defeat For CellPro, Inc.
• May 19, 1997, Elaine Lafferty By His Own Device: A biotech lab races to perfect a new treatment for cancer just in time to save its dying CEO. Time, MAY 19, 1997 VOL. 149 NO. 20.
• May 7, 1997, ABC News Report: Twist Of Fate -Biotech CEO Becomes Guinea Pig For Own Cancer Cure.
• June 1996. Elise Hancock for John Hopkins Magazine. Stalking the Stem Cell.